Peripheral blood lymphocytes analysis detects CD100/SEMA4D alteration in systemic sclerosis patients

References

• Guiducci S, Distler O, Distler JH, Matucci-Cerinic M. Mechanisms of vascular damage in SSc-implications for vascular treatment strategies. Rheumatology (Oxford). 2008; 47:v18–v20.
   Google Scholar
• Denton CP. Renal manifestations of systemic sclerosis–clinical features and outcome assessment. Rheumatology (Oxford). 2008; 47:v54–v56.
   PubMed Web of Science ®Google Scholar
• Varga J. Systemic sclerosis: an update. Bull NYU Hosp Jt Dis. 2008; 66:198–202.
   PubMedGoogle Scholar
• Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214:199–210.
   PubMed Web of Science ®Google Scholar
• Goh NS, Du Bois RM. 2004. Interstitial disease in systemic sclerosis. In: Wells AU, Denton CP. editors. Pulmonary involvement in systemic autoimmune diseases, Vol. 2 (Handbook of Systemic Autoimmune Diseases). Amsterdam: Elsevier BV. 181–208.
   Google Scholar
• Krieg T, Abraham D, Lafyatis R. Fibrosis in connective tissue disease: The role of the myofibroblast and fibroblast–epithelial cell interactions. Arthritis Res Ther. 2007; 9:S4.
   PubMed Web of Science ®Google Scholar
• Burwell T, Delaney T, Chen C, Connor J, Coyle AJ, Lemaire R. Alterations in both coagulation and fibrinolytic pathways mediate thrombosis in the skin during murine graft-versus-host (GVH)-induced scleroderma. J Immunol. 2009; 182:48.5.
   Google Scholar
• Zuber JP, Spertini F. Immunological basis of systemic sclerosis. Rheumatology (Oxford). 2006; 45:iii23–iii25.
   Google Scholar
• Kawai M, Masuda A, Kuwana M. A CD40–CD154 interaction in tissue fibrosis. Arthritis Rheum. 2008; 58:3562–3573.
   PubMed Web of Science ®Google Scholar
• Chizzolini C. T lymphocyte and fibroblast interactions: The case of skin involvement in systemic sclerosis and other examples. Springer Semin Immunopathol. 1999; 21:431–450.
   Google Scholar
• Szegedi A, Czirják L, Unkeless JC, Boros P. Serum cytokine and anti-Fc gamma R autoantibody measurements in patients with systemic sclerosis. Acta Derm Venereol. 1996; 76:21–23.
   Google Scholar
• Boin F, De Fanis U, Bartlett SJ, Wigley FM, Rosen A, Casolaro V. T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum. 2008; 58:1165–1174.
   PubMed Web of Science ®Google Scholar
• Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol. 2000; 85:9–18 quiz 18, 21.
   PubMed Web of Science ®Google Scholar
• Chizzolini C. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2008; 20:707–712.
   Google Scholar
• Boin F, Rosen A. Autoimmunity in systemic sclerosis: Current concepts. Curr Rheumatol Rep. 2007; 9:165–172.
   PubMedGoogle Scholar
• Fujimoto M, Sato S. B lymphocytes and systemic sclerosis. Curr Opin Rheumatol. 2005; 17:746–751.
   PubMed Web of Science ®Google Scholar
• Kikutani H, Kumanogoh A. Semaphorins in interactions between T cells and antigen-presenting cells. Nat Rev Immunol. 2003; 3:159–167.
   PubMed Web of Science ®Google Scholar
• Bougeret C, Mansur IG, Dastot H, Schmid M, Mahouy G, Bensussan A, Boumsell L. Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation. J Immunol. 1992; 148:318–323.
   PubMed Web of Science ®Google Scholar
• Billard C, Delaire S, Raffoux E, Bensussan A, Boumsell L. Switch in the protein tyrosine phosphatase associated with human CD100 semaphorin at terminal B-cell differentiation stage. Blood. 2000; 95:965–972.
   PubMed Web of Science ®Google Scholar
• Mizrahi S, Markel G, Porgador A, Bushkin Y, Mandelboim O. CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72. PLoS ONE. 2007; 2:e818.
   Google Scholar
• Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, Cieslak M, Fan R, Boumsell L, Kumanogoh A, Kikutani H, Tamagnone L, Wagner DD, Milla ME, Brass LF. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. PNAS. 2007; 104:1621–1626.
   PubMed Web of Science ®Google Scholar
• Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA, Bensussan A, Nadler LM, Freeman GJ. Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. PNAS. 1996; 93:11780–11785.
   PubMed Web of Science ®Google Scholar
• Delaire S, Billard C, Tordjman R, Chédotal A, Elhabazi A, Bensussan A, Boumsell L. Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration. J Immunol. 2001; 166:4348–4354.
   PubMed Web of Science ®Google Scholar
• Kumanogoh A, Suzuki K, Ch'ng E, Watanabe C, Marukawa S, Takegahara N, Ishida I, Sato T, Habu S, Yoshida K, Shi W, Kikutani H. Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells. J Immunol. 2002; 169:1175–1181.
   PubMed Web of Science ®Google Scholar
• Ishida I, Kumanogoh A, Suzuki K, Akahani S, Noda K, Kikutani H. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: Implications for the regulation of immune and inflammatory responses. Int Immunol. 2003; 15:1027–1034.
   PubMed Web of Science ®Google Scholar
• Kumanogoh A, Shikina T, Watanabe C, Takegahara N, Suzuki K, Yamamoto M, Takamatsu H, Prasad DV, Mizui M, Toyofuku T, Tamura M, Watanabe D, Parnes JR, Kikutani H. Requirement for CD100–CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment. Int Immunol. 2005; 17:1277–1282.
   PubMed Web of Science ®Google Scholar
• Li DH, Tung JW, Tarner IH, Snow AL, Yukinari T, Ngernmaneepothong R, Martinez OM, Parnes JR. CD72 down-modulates BCR-induced signal transduction and diminishes survival in primary mature B lymphocytes. J Immunol. 2006; 176:5321–5328.
   PubMed Web of Science ®Google Scholar
• Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, Tessier-Lavigne M, Comoglio PM. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 1999; 99:71–80.
   PubMed Web of Science ®Google Scholar
• Kumanogoh A, Watanabe C, Lee I, Wang X, Shi W, Araki H, Hirata H, Iwahori K, Uchida J, Yasui T, Matsumoto M, Yoshida K, Yakura H, Pan C, Parnes JR, Kikutani H. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: A novel mechanism for regulating B cell signaling. Immunity. 2000; 13:621–631.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions. Nat Immunol. 2008; 9:17–23.
   PubMed Web of Science ®Google Scholar
• Wu HJ, Bondada S. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function. J Clin Immunol. 2009; 29:12–21.
   PubMed Web of Science ®Google Scholar
• Adachi T, Flaswinkel H, Yakura H, Reth M, Tsubata T. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. J Immunol. 1998; 160:4662–4665.
   PubMed Web of Science ®Google Scholar
• Wu Y, Nadler MJ, Brennan LA, Gish GD, Timms JF, Fusaki N, Jongstra-Bilen J, Tada N, Pawson T, Wither J, Neel BG, Hozumi N. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1. Curr Biol. 1998; 8:1009–1017.
   PubMed Web of Science ®Google Scholar
• Shi W, Kumanogoh A, Watanabe C, Uchida J, Wang X, Yasui T, Yukawa K, Ikawa M, Okabe M, Parnes JR, Yoshida K, Kikutani H. The class IV semaphorin CD100 plays nonredundant roles in the immune system: Defective B and T cell activation in CD100-deficient mice. Immunity. 2000; 13:633–642.
   PubMed Web of Science ®Google Scholar
• Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, Kikutani H. Functional soluble CD100/Sema4D released from activated lymphocytes: Possible role in normal and pathologic immune responses. Blood. 2001; 97:3498–3504.
   PubMed Web of Science ®Google Scholar
• Elhabazi A, Delaire S, Bensussan A, Boumsell L, Bismuth G. Biological activity of soluble CD100. I. The extracellular region of CD100 is released from the surface of T lymphocytes by regulated proteolysis. J Immunol. 2001; 166:4341–4347.
   PubMed Web of Science ®Google Scholar
• Basile JR, Holmbeck K, Bugge TH, Gutkind JS. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem. 2007; 282:6899–6905.
   PubMed Web of Science ®Google Scholar
• Chabbert-de Ponnat I, Marie-Cardine A, Pasterkamp RJ, Schiavon V, Tamagnone L, Thomasset N, Bensussan A, Boumsell L. Soluble CD100 functions on human monocytes and immature dendritic cells require plexin C1 and plexin B1, respectively. Int Immunol. 2005; 17:439–447.
   PubMed Web of Science ®Google Scholar
• Hitomi Y, Tsuchiya N, Kawasaki A, Ohashi J, Suzuki T, Kyogoku C, Fukazawa T, Bejrachandra S, Siriboonrit U, Chandanayingyong D, Suthipinittharm P, Tsao BP, Hashimoto H, Honda Z, Tokunaga K. CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B. Hum Mol Genet. 2004; 13:2907–2917.
   PubMed Web of Science ®Google Scholar
• Nakano S, Morimoto S, Suzuki J, Mitsuo A, Nakiri Y, Katagiri A, Nozawa K, Amano H, Tokano Y, Hashimoto H, Takasaki Y. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis. Autoimmunity. 2007; 40:9–15.
   PubMed Web of Science ®Google Scholar
• Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980; 23:581–590.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol. 1988; 15:202–205.
   PubMed Web of Science ®Google Scholar
• Czirják L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE, EUSTAR. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis. 2007; 66:966–969.
   Web of Science ®Google Scholar
• Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF, Courtois H. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum. 2001; 45:346–354.
   PubMed Web of Science ®Google Scholar
• Li M, O'Sullivan KM, Jones LK, Semple T, Kumanogoh A, Kikutani H, Holdsworth SR, Kitching AR. CD100 enhances dendritic cell and CD4+ cell activation leading to pathogenetic humoral responses and immune complex glomerulonephritis. J Immunol. 2006; 177:3406–3412.
   PubMed Web of Science ®Google Scholar
• Basile JR, Afkhami T, Gutkind JS. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway. Mol Cell Biol. 2005; 25:6889–6898.
   PubMed Web of Science ®Google Scholar
• Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One. 2009; 4:e5903.
   PubMed Web of Science ®Google Scholar
• Sato S, Hasegawa M, Fujimoto M, Tedder TF, Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol. 2000; 165:6635–6643.
   PubMed Web of Science ®Google Scholar
• Yoshizaki A, Iwata Y, Komura K, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Tedder TF, Sato S. CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol. 2008; 172:1650–1663.
   PubMed Web of Science ®Google Scholar
• Tsuchiya N, Kuroki K, Fujimoto M, Murakami Y, Tedder TF, Tokunaga K, Takehara K, Sato S. Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. Arthritis Rheum. 2004; 50:4002–4007.
   PubMed Web of Science ®Google Scholar
• Giraudon P, Vincent P, Vuaillat C, Verlaeten O, Cartier L, Marie-Cardine A, Mutin M, Bensussan A, Belin MF, Boumsell L. Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells. J Immunol. 2004; 172:1246–1255.
   PubMed Web of Science ®Google Scholar